Drug intelligence / Profile preview

quercetin

Development stage
Phase 4
Lead developer
Xi'an Tianguangyuan Biotechnology
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Quercetin is a naturally occurring plant pigment (flavonoid) found in many fruits and vegetables such as onions, apples, berries, and green tea. It is widely available as a dietary supplement. Quercetin exhibits antioxidant and anti-inflammatory properties by scavenging free radicals and stabilizing cells that release histamine[2][3][5]. Its mechanisms of action include inhibition of histamine release (antihistamine effect), modulation of the mechanistic target of rapamycin (mTOR) pathway through activation of AMP-activated protein kinase (AMPK), induction of autophagy via mTORC1 inhibition and TFEB nuclear translocation[6], as well as influencing multiple cell death pathways including apoptosis and necroptosis[6]. Quercetin has been studied for potential benefits in cardiovascular disease prevention (antihypertensive effects), cancer chemoprevention or adjunctive therapy in chemotherapy regimens[2][3], allergy symptom relief due to its antihistaminic activity[1][3], neuroprotection in Parkinson’s disease models[1], diabetes management through effects on glucose metabolism[8], and other inflammatory conditions. However, most clinical evidence remains limited or inconclusive; much research has been conducted in vitro or in animal models rather than large-scale human trials.

Other names
pentahydroxyflavonequercetinevitamin P
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)Mechanistic target of rapamycin complex 1CLEC12ACK2 (Casein kinase II subunit alpha)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)

Beyond the preview

Go deeper on quercetin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quercetin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call